Gastroenterology & Hepatology Advanced Practice Providers (GHAPP)
01/27/2026
Systemic therapy, liver-directed therapy… or is the real answer combination therapy? 💡
Allysa Saggese, NP breaks down how to balance systemic and liver-directed therapies in MASH—highlighting guideline-aligned options, combination strategies, and why individualized, multimodal care is the future of MASH management.
Meet Jonathan Yeh, PA, a member of the MASLD Community Network, dedicated to advancing education, awareness, and better care for patients with metabolic liver disease!
Meet Maly Tiev, NP, a dedicated voice within the MASLD Community Network—supporting education, awareness, and better care for patients with metabolic liver disease. Follow along for expert insights, real-world guidance, and resources built for APPs on the front lines.
The 14th Annual Advances in GI & Hepatology Conference is next week! Join us on Saturday, January 31 at for key updates on managing GI and liver disorders. Register now https://loom.ly/ZtaJ23E
01/21/2026
Meet the Northeast Region experts of the MASLD Community Network. These APP leaders are advancing education, awareness, and real-world care for patients with MASLD and MASH across the region 🗺️
Join us on February 10 at 7:00 PM ET for a practical webinar on the current standards and real-world application of direct-acting antiviral (DAA) therapies!
Hear expert insights from Patrick Horne, NP and Philip Stine, MD as they break down how to apply DAA therapy with confidence in everyday practice.
Alcohol use can change the entire MASH conversation 🥃.
In this FAQ, Alison Moe, PA-C, explains how alcohol and metabolic liver disease interact, when intake becomes clinically meaningful, and how biomarkers like PEth support accurate diagnosis and documentation—key insights for APPs managing MASH, ALD, and MetALD.
Want real-world MASLD insights you can actually use in practice?🤔
Follow Erin Tanner on the MASLD Community Network for practical insights, real-world perspectives, and content designed for APPs on the front lines of metabolic liver disease.
Breakthroughs in MASH Diagnosis and Management is coming to cities nationwide as part of the Liver Connect City Series. Stay current on evolving MASH care and find a meeting near you: https://loom.ly/0-N_WZo 🗺️
01/12/2026
Looking to hear how Sarah Dawkins, FNP-C, MSN, RN, navigates NITs in practice? Watch her concise overview on when and how to use non-invasive tests to support clinical decision making👇 https://loom.ly/kY_UUBs
01/08/2026
RUSH Into GI is coming up! Join the expert faculty at RUSH on January 30–31, 2026 in Chicago for two days of GI-focused education and connection.
Advancing MASLD care starts with connection. Follow leading experts across the Southwest who are shaping how MASLD is understood, diagnosed, and managed in real-world practice!🤓
Be the first to know and let us send you an email when GHAPP posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.
The Gastroenterology & Hepatology Advanced Practice Providers (GHAPP) association is dedicated to developing educational programs, providing professional advancement services, and assembling resources for—and guided by—advanced practice providers (APPs).
Through our peer-to-peer network, we seek to support their integral role in the specialty healthcare community by providing the most relevant and timely information and communication for the treatment of their patients with gastrointestinal (GI) disorders and chronic liver disease (CLD).
Partners
We expand our reach and access through dedicated partnerships with; American Society for Gastrointestinal Endoscopy (ASGE), Annenberg Center for Health Sciences at Eisenhower, CE Outcomes (Independent Outcomes Assessment), Chronic Liver Disease Foundation (CLDF), Collaborative Alliance for Pancreatic Education and Research (CAPER), Collaborative Group of the Americas on Inherited Gastrointestinal Cancer (CGA), Gi Health Foundation (GIHF)
For more information visit our website or follow us on Twitter.